本页面由Tiger Trade Technology Pte. Ltd.提供服务

Kymera Therapeutics, Inc.

79.67
-2.5400-3.09%
盘前80.400.7300+0.92%07:33 EDT
成交量:68.11万
成交额:5,471.18万
市值:65.53亿
市盈率:-22.47
高:83.41
开:82.41
低:79.07
收:82.21
52周最高:103.00
52周最低:28.06
股本:8,225.76万
流通股本:5,462.66万
量比:1.64
换手率:1.25%
股息:- -
股息率:- -
每股收益(TTM):-3.5458
每股收益(LYR):-3.6900
净资产收益率:-27.09%
总资产收益率:-17.16%
市净率:4.26
市盈率(LYR):-21.59

数据加载中...

2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/06

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities